Prof Kathleen Brady is a prominent leader in the substance abuse field at an international level and well known for her research in the area of psychiatric comorbidity and substance use disorders.She directs the renowned South Carolina Clinical and Translational Research Centre, a $19 million centre devoted to translation of research to practice. Prof Brady has received a number of distinguished awards throughout her career, and in 2010, she was the most highly NIH-funded psychiatrist in the USA. Her research activities involve the interface between basic and clinical science investigating the mechanistic connection between stress and substance use disorders and in the translation of empirically-based treatments from academic medical centres to front-line treatment settings. Dr. Brady is the Principal Investigator and Director of the Southern Consortium of the NIDA Clinical Trials Network. She also holds the titles of director of clinical programs in MUSC's Clinical Neuroscience Division and director of the South Carolina Clinical and Translational Research Institute (SCTR).